MX2015009606A - Uso de un péptido natriurético, un péptido diurético o un péptido vasodilatador en la elaboración de un medicamento para tratar una condición cardiovascular. - Google Patents
Uso de un péptido natriurético, un péptido diurético o un péptido vasodilatador en la elaboración de un medicamento para tratar una condición cardiovascular.Info
- Publication number
- MX2015009606A MX2015009606A MX2015009606A MX2015009606A MX2015009606A MX 2015009606 A MX2015009606 A MX 2015009606A MX 2015009606 A MX2015009606 A MX 2015009606A MX 2015009606 A MX2015009606 A MX 2015009606A MX 2015009606 A MX2015009606 A MX 2015009606A
- Authority
- MX
- Mexico
- Prior art keywords
- peptide
- vaso
- dilatory
- methods
- diuretic
- Prior art date
Links
- 108020001621 Natriuretic Peptide Proteins 0.000 title abstract 2
- 102000004571 Natriuretic peptide Human genes 0.000 title abstract 2
- 230000002526 effect on cardiovascular system Effects 0.000 title abstract 2
- 239000000692 natriuretic peptide Substances 0.000 title abstract 2
- 101710158332 Diuretic hormone Proteins 0.000 title 1
- 101710204261 Diuretic hormone class 2 Proteins 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000000304 vasodilatating effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2221—Relaxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Dermatology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361756692P | 2013-01-25 | 2013-01-25 | |
| PCT/IB2014/000253 WO2014115033A2 (en) | 2013-01-25 | 2014-01-24 | Methods of treating cardiovascular indications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015009606A true MX2015009606A (es) | 2016-04-26 |
Family
ID=50382492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015009606A MX2015009606A (es) | 2013-01-25 | 2014-01-24 | Uso de un péptido natriurético, un péptido diurético o un péptido vasodilatador en la elaboración de un medicamento para tratar una condición cardiovascular. |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20140213520A1 (enExample) |
| EP (1) | EP2948165A2 (enExample) |
| JP (1) | JP2016505065A (enExample) |
| KR (1) | KR20150108903A (enExample) |
| CN (1) | CN105025918A (enExample) |
| AP (1) | AP2015008624A0 (enExample) |
| AU (1) | AU2014208851B2 (enExample) |
| BR (1) | BR112015017432A2 (enExample) |
| CA (1) | CA2898571A1 (enExample) |
| DO (1) | DOP2015000175A (enExample) |
| EA (1) | EA201500765A1 (enExample) |
| IL (1) | IL239909A0 (enExample) |
| MX (1) | MX2015009606A (enExample) |
| NZ (1) | NZ710246A (enExample) |
| PH (1) | PH12015501559A1 (enExample) |
| SG (1) | SG11201505492XA (enExample) |
| TN (1) | TN2015000315A1 (enExample) |
| TW (1) | TW201442722A (enExample) |
| WO (1) | WO2014115033A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015184248A1 (en) * | 2014-05-30 | 2015-12-03 | Concert Pharmaceuticals, Inc. | Methods of treating fibrotic diseases |
| CN105617360B (zh) * | 2015-12-04 | 2018-12-21 | 中国农业大学 | C-型钠肽在制备外用避孕药和精子功能检测试剂中的应用 |
| AU2017368050A1 (en) | 2016-11-29 | 2019-06-20 | Puretech Lyt, Inc. | Exosomes for delivery of therapeutic agents |
| CN110278941B (zh) * | 2019-07-11 | 2021-05-28 | 西安国际医学中心有限公司 | 一种含有钠尿肽的离体心脏保护液 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3346953A1 (de) | 1983-12-24 | 1985-08-14 | Organogen Medizinisch-Molekularbiologische Forschungsgesellschaft mbH, 6900 Heidelberg | Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung |
| US5449751A (en) | 1987-03-02 | 1995-09-12 | Pharma Bissendorf Peptide Gmbh | Cardiodilatin fragment, process for preparing same and use thereof |
| US5461142A (en) | 1987-11-07 | 1995-10-24 | Pharma Bissendorf Peptide Gmbh | Phosphorylated derivatives of cardiodilatin/ANF peptides |
| US5166191A (en) * | 1991-08-19 | 1992-11-24 | Genentech, Inc. | Use of relaxin in cardiovascular therapy |
| DE4216133A1 (de) | 1992-05-15 | 1993-11-18 | Bissendorf Peptide Gmbh | Anwendung von Urodilatin bei Lungen- und Bronchialerkrankungen |
| ES2188665T3 (es) | 1994-06-02 | 2003-07-01 | Forssmann Wolf Georg | Procedimiento para la preparacion de fragmentos de cardiodilatina, fragmentos de cardiodilatina muy purificados y productos intermedios para su preparacion. |
| DE19951471A1 (de) | 1999-10-26 | 2001-05-03 | Forssmann Wolf Georg | Verwendung von Urodilatin zur Behandlung chronischer Niereninsuffizienz mit Nierenrestfunktionen |
| US6407211B1 (en) * | 1999-12-17 | 2002-06-18 | Mayo Foundation For Medical Education And Research | Chimeric natriuretic peptides |
| NZ525389A (en) * | 2000-10-04 | 2009-04-30 | Molecular Medicine Res Inst | Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| KR101271635B1 (ko) * | 2001-12-21 | 2013-06-12 | 휴먼 게놈 사이언시즈, 인코포레이티드 | 알부민 융합 단백질 |
| US20050113286A1 (en) * | 2002-03-18 | 2005-05-26 | Schreiner George F. | Methods for treating congestive heart failure |
| WO2006110743A1 (en) * | 2005-04-07 | 2006-10-19 | Cardiopep Pharma Gmbh | Use of natriuretic peptide for treating heart failure |
| US8293711B2 (en) * | 2007-09-11 | 2012-10-23 | Pharis Biotech Gmbh | Use of natriuretic peptides for treating angioedema syndromes |
| WO2009086126A2 (en) * | 2007-12-21 | 2009-07-09 | Mayo Foundation For Medical Education And Research | Natriuretic polypeptides |
| CN104815319A (zh) * | 2008-05-16 | 2015-08-05 | 科尔泰拉公司 | 治疗慢性心力衰竭的方法 |
| WO2010048308A2 (en) * | 2008-10-24 | 2010-04-29 | Deborah Dickey | Natriuretic polypeptides |
| JP2010116325A (ja) * | 2008-11-11 | 2010-05-27 | Institute For Protein Science Co Ltd | Ｓｉｒｓ患者を救命するためのペプチド組成物 |
| US20110014180A1 (en) * | 2009-07-16 | 2011-01-20 | Masafumi Koide | Preparations for tissue restoration containing atrial diuretic hormone and family molecules as active ingredients; method of restoring tissue using the preparation; agents for growing, restoring, promoting growth of hair and agents for promoting restoration of skin tissue and cardiac muscle tissue containing atrial diuretic hormone family molecules as active ingredients; method of growing, restoring, promoting growth of hair by using the agents; and method of promoting restoration of skin tissue and cardiac muscle tissue |
| UY32902A (es) * | 2009-09-25 | 2011-02-28 | Alcon Res Ltd | Nuevos agonistas de npr-b |
| US8551938B2 (en) * | 2009-09-25 | 2013-10-08 | Alcon Research, Ltd. | NPR-B agonists |
| US20130197188A1 (en) * | 2010-03-15 | 2013-08-01 | Wolf-Georg Forssmann | Use of urodilatin for preparing a medicament for the treatment of cardiovascular, renal, pulmonary and neuronal syndromes while avoiding a rebound |
| US20120052097A1 (en) * | 2010-08-20 | 2012-03-01 | Cerulean Pharma Inc. | Therapeutic peptide-polymer conjugates, particles, compositions, and related methods |
-
2014
- 2014-01-24 WO PCT/IB2014/000253 patent/WO2014115033A2/en not_active Ceased
- 2014-01-24 TW TW103102790A patent/TW201442722A/zh unknown
- 2014-01-24 SG SG11201505492XA patent/SG11201505492XA/en unknown
- 2014-01-24 EP EP14712761.7A patent/EP2948165A2/en not_active Withdrawn
- 2014-01-24 US US14/163,273 patent/US20140213520A1/en not_active Abandoned
- 2014-01-24 CA CA2898571A patent/CA2898571A1/en not_active Abandoned
- 2014-01-24 BR BR112015017432A patent/BR112015017432A2/pt not_active IP Right Cessation
- 2014-01-24 NZ NZ710246A patent/NZ710246A/en not_active IP Right Cessation
- 2014-01-24 AP AP2015008624A patent/AP2015008624A0/xx unknown
- 2014-01-24 AU AU2014208851A patent/AU2014208851B2/en not_active Ceased
- 2014-01-24 CN CN201480013163.1A patent/CN105025918A/zh active Pending
- 2014-01-24 JP JP2015554265A patent/JP2016505065A/ja active Pending
- 2014-01-24 MX MX2015009606A patent/MX2015009606A/es unknown
- 2014-01-24 KR KR1020157022509A patent/KR20150108903A/ko not_active Withdrawn
- 2014-01-24 EA EA201500765A patent/EA201500765A1/ru unknown
- 2014-01-24 US US14/163,130 patent/US20140213519A1/en not_active Abandoned
-
2015
- 2015-07-13 IL IL239909A patent/IL239909A0/en unknown
- 2015-07-13 PH PH12015501559A patent/PH12015501559A1/en unknown
- 2015-07-23 TN TN2015000315A patent/TN2015000315A1/en unknown
- 2015-07-24 DO DO2015000175A patent/DOP2015000175A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ710246A (en) | 2016-11-25 |
| WO2014115033A3 (en) | 2015-02-26 |
| WO2014115033A2 (en) | 2014-07-31 |
| JP2016505065A (ja) | 2016-02-18 |
| AU2014208851B2 (en) | 2016-12-22 |
| CA2898571A1 (en) | 2014-07-31 |
| DOP2015000175A (es) | 2015-11-15 |
| KR20150108903A (ko) | 2015-09-30 |
| US20140213520A1 (en) | 2014-07-31 |
| AU2014208851A1 (en) | 2015-08-06 |
| BR112015017432A2 (pt) | 2017-07-11 |
| EA201500765A1 (ru) | 2015-12-30 |
| SG11201505492XA (en) | 2015-08-28 |
| US20140213519A1 (en) | 2014-07-31 |
| TN2015000315A1 (en) | 2017-01-03 |
| CN105025918A (zh) | 2015-11-04 |
| TW201442722A (zh) | 2014-11-16 |
| PH12015501559A1 (en) | 2015-09-21 |
| AP2015008624A0 (en) | 2015-07-31 |
| IL239909A0 (en) | 2015-08-31 |
| EP2948165A2 (en) | 2015-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2523013A (en) | Method and system to detect and select best photographs | |
| UA115811C2 (uk) | Стабільний розчин об'єднаних баклофену, сорбіту і налтрексону для перорального застосування | |
| HK1214752A1 (zh) | 由产甲烷菌引起或与之相关的疾病及病状的诊断、选择及治疗方法 | |
| MX362861B (es) | Metodos y composiciones para tratar esclerosis multiple y trastornos relacionadods. | |
| IN2014DN07247A (enExample) | ||
| MX2014010940A (es) | El uso de antitrombina en el tratamiento de preeclampsia. | |
| EP4509616A3 (en) | Use of cd36 to identify cancer subjects for treatment | |
| MX2021003826A (es) | Benralizumab para usarse en el tratamiento de asma incrementando el volumen espiratorio forzado. | |
| WO2014140362A3 (en) | Lymphocyte biomarkers for determining the clinical response to therapy with mesenschymal stromal cells(msc) | |
| MX2015009606A (es) | Uso de un péptido natriurético, un péptido diurético o un péptido vasodilatador en la elaboración de un medicamento para tratar una condición cardiovascular. | |
| MX2015015519A (es) | Regulador de papalisina. | |
| MX2016001686A (es) | Composicion para el tratamiento contra el envejecimiento de la piel. | |
| MX2016001948A (es) | Método para diagnosticar un tumor pulmonar maligno. | |
| MX2018004296A (es) | Combinacion de un agonista selectivo de il-2rbeta y un agonista il-15 de accion prolongada. | |
| WO2015023631A3 (en) | Fatty acid analogs and their use | |
| GB2528406A (en) | Prebiotic composition and method of its use | |
| SG10201809418VA (en) | New administration routes of insulin, insulin analogs or derivatives of insulin | |
| UA44660U (ru) | Способ лечения больных системными заболеваниями соединительной ткани с преимущественным поражением кожи | |
| UA100317C2 (uk) | Спосіб визначення фізіологічного стану організму людини | |
| UA104625U (uk) | Спосіб визначення глибини дермального ураження при опіках | |
| PH12015502305A1 (en) | Use of pidotimod to treat inflammatory bowel disease | |
| UA59920U (ru) | Способ диагностики тиреотоксикоза | |
| UA83553U (ru) | Способ прогнозирования развития рецидивирующего течения пиелонефрита | |
| UA67342U (ru) | Способ оценки жизненной емкости легких у здоровых людей | |
| PH12015502304A1 (en) | Use of pidotimod to treat irritable bowel syndrome |